The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Ringworm Treatment-Global Market Insights and Sales Trends 2024
Synopsis
Ringworm is a common fungal infection of skin. Tinea is the medical term used for ringworm. The infection is caused by skin fungi called dermatophytes. Ringworm infection can cause scaly, red, and round patches on skin. It can also cause patches of hair loss, itching, blisters, and scaling of scalp. The infection can affect various areas such as skin of scalp, feet, beard, and groin. Ringworm is highly contagious and can be transmitted through animals. The infection can be treated successfully with certain antifungal and over-the-counter medicines.
The global Ringworm Treatment market size is expected to reach US$ 18290 million by 2029, growing at a CAGR of 4.0% from 2023 to 2029. The market is mainly driven by the significant applications of Ringworm Treatment in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Ringworm Treatment market. Steroids, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antifungals segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Ringworm Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Ringworm Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Ringworm Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Ringworm Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Ringworm Treatment covered in this report include Perrigo Company, Novartis, GlaxoSmithKline, Teva Pharmaceuticals, Taro Pharmaceutical, Glenmark Pharmaceuticals, Quinnova Pharmaceuticals, Sun Pharmaceutical and Bausch Health, etc.
The global Ringworm Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Perrigo Company
Novartis
GlaxoSmithKline
Teva Pharmaceuticals
Taro Pharmaceutical
Glenmark Pharmaceuticals
Quinnova Pharmaceuticals
Sun Pharmaceutical
Bausch Health
Merz Pharma
Global Ringworm Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ringworm Treatment market, Segment by Type:
Steroids
Antifungals
Anti-Infectives
Others
Global Ringworm Treatment market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Ringworm Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Ringworm is a common fungal infection of skin. Tinea is the medical term used for ringworm. The infection is caused by skin fungi called dermatophytes. Ringworm infection can cause scaly, red, and round patches on skin. It can also cause patches of hair loss, itching, blisters, and scaling of scalp. The infection can affect various areas such as skin of scalp, feet, beard, and groin. Ringworm is highly contagious and can be transmitted through animals. The infection can be treated successfully with certain antifungal and over-the-counter medicines.
The global Ringworm Treatment market size is expected to reach US$ 18290 million by 2029, growing at a CAGR of 4.0% from 2023 to 2029. The market is mainly driven by the significant applications of Ringworm Treatment in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Ringworm Treatment market. Steroids, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antifungals segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Ringworm Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Ringworm Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Ringworm Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Ringworm Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Ringworm Treatment covered in this report include Perrigo Company, Novartis, GlaxoSmithKline, Teva Pharmaceuticals, Taro Pharmaceutical, Glenmark Pharmaceuticals, Quinnova Pharmaceuticals, Sun Pharmaceutical and Bausch Health, etc.
The global Ringworm Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Perrigo Company
Novartis
GlaxoSmithKline
Teva Pharmaceuticals
Taro Pharmaceutical
Glenmark Pharmaceuticals
Quinnova Pharmaceuticals
Sun Pharmaceutical
Bausch Health
Merz Pharma
Global Ringworm Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ringworm Treatment market, Segment by Type:
Steroids
Antifungals
Anti-Infectives
Others
Global Ringworm Treatment market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Ringworm Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Ringworm Treatment
1.1 Ringworm Treatment Market Overview
1.1.1 Ringworm Treatment Product Scope
1.1.2 Ringworm Treatment Market Status and Outlook
1.2 Global Ringworm Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Ringworm Treatment Market Size by Region (2018-2029)
1.4 Global Ringworm Treatment Historic Market Size by Region (2018-2023)
1.5 Global Ringworm Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Ringworm Treatment Market Size (2018-2029)
1.6.1 North America Ringworm Treatment Market Size (2018-2029)
1.6.2 Europe Ringworm Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Ringworm Treatment Market Size (2018-2029)
1.6.4 Latin America Ringworm Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Ringworm Treatment Market Size (2018-2029)
2 Ringworm Treatment Market by Type
2.1 Introduction
2.1.1 Steroids
2.1.2 Antifungals
2.1.3 Anti-Infectives
2.1.4 Others
2.2 Global Ringworm Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Ringworm Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Ringworm Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Ringworm Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Ringworm Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Ringworm Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Ringworm Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Ringworm Treatment Revenue Breakdown by Type (2018-2029)
3 Ringworm Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global Ringworm Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Ringworm Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Ringworm Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Ringworm Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Ringworm Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Ringworm Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Ringworm Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Ringworm Treatment Revenue Breakdown by Application (2018-2029)
4 Ringworm Treatment Competition Analysis by Players
4.1 Global Ringworm Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ringworm Treatment as of 2022)
4.3 Date of Key Players Enter into Ringworm Treatment Market
4.4 Global Top Players Ringworm Treatment Headquarters and Area Served
4.5 Key Players Ringworm Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Ringworm Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Perrigo Company
5.1.1 Perrigo Company Profile
5.1.2 Perrigo Company Main Business
5.1.3 Perrigo Company Ringworm Treatment Products, Services and Solutions
5.1.4 Perrigo Company Ringworm Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Perrigo Company Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Ringworm Treatment Products, Services and Solutions
5.2.4 Novartis Ringworm Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Novartis Recent Developments
5.3 GlaxoSmithKline
5.3.1 GlaxoSmithKline Profile
5.3.2 GlaxoSmithKline Main Business
5.3.3 GlaxoSmithKline Ringworm Treatment Products, Services and Solutions
5.3.4 GlaxoSmithKline Ringworm Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Teva Pharmaceuticals Recent Developments
5.4 Teva Pharmaceuticals
5.4.1 Teva Pharmaceuticals Profile
5.4.2 Teva Pharmaceuticals Main Business
5.4.3 Teva Pharmaceuticals Ringworm Treatment Products, Services and Solutions
5.4.4 Teva Pharmaceuticals Ringworm Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Teva Pharmaceuticals Recent Developments
5.5 Taro Pharmaceutical
5.5.1 Taro Pharmaceutical Profile
5.5.2 Taro Pharmaceutical Main Business
5.5.3 Taro Pharmaceutical Ringworm Treatment Products, Services and Solutions
5.5.4 Taro Pharmaceutical Ringworm Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Taro Pharmaceutical Recent Developments
5.6 Glenmark Pharmaceuticals
5.6.1 Glenmark Pharmaceuticals Profile
5.6.2 Glenmark Pharmaceuticals Main Business
5.6.3 Glenmark Pharmaceuticals Ringworm Treatment Products, Services and Solutions
5.6.4 Glenmark Pharmaceuticals Ringworm Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Glenmark Pharmaceuticals Recent Developments
5.7 Quinnova Pharmaceuticals
5.7.1 Quinnova Pharmaceuticals Profile
5.7.2 Quinnova Pharmaceuticals Main Business
5.7.3 Quinnova Pharmaceuticals Ringworm Treatment Products, Services and Solutions
5.7.4 Quinnova Pharmaceuticals Ringworm Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Quinnova Pharmaceuticals Recent Developments
5.8 Sun Pharmaceutical
5.8.1 Sun Pharmaceutical Profile
5.8.2 Sun Pharmaceutical Main Business
5.8.3 Sun Pharmaceutical Ringworm Treatment Products, Services and Solutions
5.8.4 Sun Pharmaceutical Ringworm Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Sun Pharmaceutical Recent Developments
5.9 Bausch Health
5.9.1 Bausch Health Profile
5.9.2 Bausch Health Main Business
5.9.3 Bausch Health Ringworm Treatment Products, Services and Solutions
5.9.4 Bausch Health Ringworm Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Bausch Health Recent Developments
5.10 Merz Pharma
5.10.1 Merz Pharma Profile
5.10.2 Merz Pharma Main Business
5.10.3 Merz Pharma Ringworm Treatment Products, Services and Solutions
5.10.4 Merz Pharma Ringworm Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Merz Pharma Recent Developments
6 North America
6.1 North America Ringworm Treatment Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Ringworm Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Ringworm Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Ringworm Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Ringworm Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Ringworm Treatment Market Dynamics
11.1 Ringworm Treatment Industry Trends
11.2 Ringworm Treatment Market Drivers
11.3 Ringworm Treatment Market Challenges
11.4 Ringworm Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
